Showing results (131-140 of 236) with videos related to
Sort By:
Pageof 24
Journal of the International AIDS Society|June 12, 2021
No need for secondary Pneumocystis jirovecii pneumonia prophylaxis in adult people living with HIV from Europe on ART with suppressed viraemia and a CD4 cell count greater than 100 cells/µLAndrew Atkinson, Jose M Miro, Amanda Mocroft, et al.BMC Medicine|April 3, 2016
Is there continued evidence for an association between abacavir usage and myocardial infarction risk in individuals with HIV? A cohort collaborationCaroline A Sabin, Peter Reiss, Lene Ryom, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|December 22, 2020
Effect of Changes in Body Mass Index on the Risk of Cardiovascular Disease and Diabetes Mellitus in HIV-Positive Individuals: Results From the D:A:D StudyKathy Petoumenos, Locadiah Kuwanda, Lene Ryom, et al.AIDS (London, England)|August 3, 2019
Prevalence and risk factors of prolonged QT interval and electrocardiographic abnormalities in persons living with HIVAndreas Dehlbæk Knudsen, Klaus Fuglsang Kofoed, Marco Gelpi, et al.International Journal of Antimicrobial Agents|July 3, 2017
Impact of early versus deferred antiretroviral therapy on estimated glomerular filtration rate in HIV-positive individuals in the START trialAmit C Achhra, Amanda Mocroft, Michael Ross, et al.Epidemiology (Cambridge, Mass.)|April 28, 2011
The Coding Causes of Death in HIV (CoDe) Project: initial results and evaluation of methodologyJustyna D Kowalska, Nina Friis-Møller, Ole Kirk, et al.AIDS (London, England)|August 7, 2019
Serious clinical events in HIV-positive persons with chronic kidney diseaseLene Ryom, Jens D Lundgren, Matthew Law, et al.Journal of Hepatology|January 23, 2023
External validation of the PAGE-B score for HCC risk prediction in people living with HIV/HBV coinfectionBernard Surial, Adrià Ramírez Mena, Marie Roumet, et al.Plos One|January 29, 2019
Body composition and adipokines changes after initial treatment with darunavir-ritonavir plus either raltegravir or tenofovir disoproxil fumarate-emtricitabine: A substudy of the NEAT001/ANRS143 randomised trialJose I Bernardino, Amanda Mocroft, Cedrick Wallet, et al.AIDS (London, England)|March 8, 2016
Improvements over time in short-term mortality following myocardial infarction in HIV-positive individualsCamilla Ingrid Hatleberg, Lene Ryom, Wafaa El-Sadr, et al.Pageof 24